Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_4

20%

Ph not_applicable

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Other(2)

Detailed Status

Completed3

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (25.0%)

N/A3 (75.0%)

Trials by Status

unknown240%

completed360%

Recent Activity

0 active trials

Showing 5 of 5

unknownnot_applicable

Prospective Study for Vaginal Vault Prolapse After Hysterectomy: Comparison of Two Surgical Methods

NCT02290288

completed

Evaluate Women After Vaginal Surgery for Urinary Symptoms and Sexual Function

NCT00376441

Clinical Trials (5)

Showing 5 of 5 trials

NCT05628831Not Applicable

Traditional Vaginal Surgery VS Autologous Tissue in Pelvic Floor Repair

Unknown

NCT03446950Not Applicable

Study Investigating Role of Unalike Patient Positioning on PROMIS Scores

Completed

NCT02906111Phase 4

Vaginal Estriol Before and Vaginal Surgery for Prolapse

Unknown

NCT02290288Not Applicable

Prospective Study for Vaginal Vault Prolapse After Hysterectomy: Comparison of Two Surgical Methods

Completed

NCT00376441

Evaluate Women After Vaginal Surgery for Urinary Symptoms and Sexual Function

Completed

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5